Form 4 for IQV IQVIA
Accepted 2022-02-14 00:00:00 ET · period of report 2022-02-10 · accession 0001478242-22-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-14 | 2022-02-10 | IQV | BOUSBIB ARI | See Remarks, Dir | A - Grant | $0.00 | +20.5K | 713.7K | +3% | $0 |
| D | 2022-02-14 | 2022-02-10 | IQV | BOUSBIB ARI | See Remarks, Dir | A - Grant | $0.00 | +76.5K | 76.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-10 | A | A | 20,542 | $0.00 | 713,740 | D | — | — | (F1) Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023. |
| 2 | Derivative | Stock Appreciation Right | 2022-02-10 | A | A | 76,472 | $0.00 | 76,472 | D | $250.43 · — to 2032-02-10 | 76,472 Common Stock | (F3) The stock appreciation right vests in three annual installments beginning on February 10, 2023. |